12:00 AM
 | 
Mar 19, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Minocycline foam: Phase II data

A double-blind, Israeli Phase II trial in 32 patients aged 2-15 showed that twice-daily 1% and 4% formulations of topical Minocycline foam for 7 days led to clinical success rates at the end of treatment and at day 14 of 100%. Clinical success was defined as the absence of treated lesions, or when treated...

Read the full 248 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >